Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × Pafolacianine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Appendiceal Neoplasms 1

Interventions

Ifosfamide 20 Methotrexate 19 Cyclophosphamide 18 Doxorubicin 16 Cisplatin 13 Gemcitabine 10 Filgrastim 10 Etoposide 10 Leucovorin 8 fludarabine 7 apatinib 7 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Zoledronic Acid 5 Vincristine 5 Temozolomide 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 Carboplatin 5 regorafenib 4 pegfilgrastim 4 glucarpidase 4 cabozantinib 4 Topotecan 4 Surveys and Questionnaires 4 Sunitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06235125 2024-08-22

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡